The U.S. Department of Health and Human Services (HHS), working jointly with the Drug Enforcement Administration (DEA), today announced a fourth temporary extension of telemedicine flexibilities that allow patients to receive prescriptions for controlled medications without a prior in-person visit. The extension runs from January 1, 2026, through December 31, 2026, preventing disruptions in care while permanent rules are finalized.
